A2M has had supply issues this half along with the plethora of...

A2M has had supply issues this half along with the plethora of regulatory issues in China and still beats guidance. Imagine what it's capable of doing if it had a clear run and could meet demand.

I have a relative in China and after what they told me last month I topped up 75,000 A2M shares @$1.60 (before it got smashed). BAL is still my larger holding. A2M's EBITA is now forecast to be higher than BAL (AUD$49-51m vs $43-47m), so finally it can justify a higher market cap. They will easily surpass $500m revenue and north of $80m EBITA in FY17.

For BAL, FY16 I'm predicting $270-275m revenue and $39m NPAT (20% margin).